Cambrex Celebrates Its 40Th Anniversary While Investing Over $100 Million In New Drug Substance Manufacturing Capacity

Cambrex recently celebrated the 40th anniversary of its founding in 1981. Following forty years of growth and transformation into a leading global contract development and manufacturing organization (CDMO), Cambrex continues its commitment to leadership in pharmaceutical drug substance manufacturing with over $100 million of investments in progress across its global manufacturing network.